Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Biden may not have used the right word when he described the pandemic as “over,” but things are trending in the right direction.
Updated boosters could go to the “worried well” who have good insurance rather than to those at highest risk.
Higher levels of viral antigens in the blood correlated with more severe disease.
Updated Pfizer-BioNTech and Moderna bivalent boosters contain spike proteins from the original and BA.4 and BA.5 omicron variants.
Whether omicron coronavirus variants cause long COVID symptoms as often—and as severe—as previous variants is a matter of heated study.
An experimental vaccine produced an immune response to a range of different coronaviruses in mice and monkeys, including SARS-CoV-2.
The engineered protein vaccine was highly effective in a clinical trial but faced a long delay for authorization.
The update aims to help the public better protect themselves and understand their risk.
Using wastewater to track the emergence of new variants of concern could be faster and less expensive than clinical testing.
New studies offer evidence that an unexpected virus plays a role—but it needs a helper.
Antibody levels decrease substantially within three months after a booster, according to new clinical trial data.
People of European or African ancestry who were hospitalized for COVID-19 are more likely to carry particular genetic variants.
The pandemic also disrupted medical care and had an indirect effect on other causes of death.
Findings from small NIH study could provide insight into long-term neurological symptoms of COVID-19.
Prolonged inflammation after SARS-CoV-2 infection caused permanent organ damage, affected the brain and correlated with behavioral changes.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.